URMC / Labs / Center for Retina and Brain / Publications

Publications

1. Bilgrami ZR
2. Castro E
3. Agurto C
4. Liebenthal E
5. Ennis M
6. Baker JT
7. Scott I
8. Colton BL
9. Cho KIK
10. Li L
11. Tamayo Z
12. Henecks M
13. Rahimi Eichi H
14. Henry T
15. Addington J
16. Alameda LK
17. Arango C
18. Breitborde NJK
19. Broome MR
20. Cadenhead KS
21. Calkins ME
22. Chen EYH
23. Choi J
24. Conus P
25. Cornblatt BA
26. Ellman LM
27. Fusar-Poli P
28. Gaspar PA
29. Gerber C
30. Glenthøj LB
31. Horton LE
32. Hui C
33. Kambeitz J
34. Kambeitz-Ilankovic L
35. Keshavan MS
36. Kim SW
37. Koutsouleris N
38. Kwon JS
39. Langbein K
40. Mamah D
41. Diaz-Caneja CM
42. Mathalon DH
43. Mittal VA
44. Nordentoft M
45. Pearlson GD
46. Perez J
47. Perkins DO
48. Powers AR
49. Rogers J
50. Sabb FW
51. Schiffman J
52. Shah JL
53. Silverstein SM
54. Smesny S
55. Stone WS
56. Yassin W
57. Strauss GP
58. Thompson JL
59. Upthegrove R
60. Verma S
61. Wang J
62. Wolf DH
63. McGorry PD
64. Kahn RS
65. Kane JM
66. Anticevic A
67. Bearden CE
68. Dwyer D
69. Billah T
70. Bouix S
71. Pasternak O
72. Shenton ME
73. Woods SW
74. Nelson B
75. Cecchi GA
76. Corcoran CM
77. Wolff PM
Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative.; Schizophrenia (Heidelberg, Germany); Vol 11(1), pp. 125. 2025 Oct 15.
1. Farina EA
2. Mourgues-Codern C
3. Stimler K
4. Kenney J
5. Saxena A
6. Mukhtar H
7. Addington J
8. Bearden CE
9. Cadenhead KS
10. Cannon TD
11. Cornblatt B
12. Ellman L
13. Gold J
14. Keshavan M
15. Mathalon DH
16. Mittal VA
17. Perkins DO
18. Schiffman J
19. Silverstein SM
20. Strauss GP
21. Stone WS
22. Walker EF
23. Waltz J
24. Corlett P
25. Powers AR
26. Woods SW
Shift in sex and age of individuals at a clinical high risk (CHR) for psychosis: relation to differences in recruitment methods and effect on sample characteristics.; Schizophrenia (Heidelberg, Germany); Vol 11(1), pp. 123. 2025 Oct 06.
1. Addington J
2. Shalev A
3. Liu L
4. Jahraus C
5. Chu M
6. Farina E
7. Fusar Poli P
8. Marcy PJ
9. Nunez AR
10. Calkins ME
11. Alameda L
12. Arango C
13. Borders O
14. Bouix S
15. Breitborde NJK
16. Broome MR
17. Cadenhead KS
18. Carrion RE
19. Castillo-Passi RI
20. Chen EYH
21. Choi J
22. Coleman MJ
23. Conus P
24. Corcoran CM
25. Diaz-Caneja CM
26. Ellman LM
27. Gaspar PA
28. Gerber C
29. Glenthøj LB
30. Horton LE
31. Hui CLM
32. Kambeitz J
33. Kambeitz-Ilankovic L
34. Kapur T
35. Kelly S
36. Kerr MJ
37. Keshavan MS
38. Kim M
39. Kim SW
40. Koutsouleris N
41. Kwon JS
42. Langbein K
43. Lewandowski KE
44. Mamah D
45. Mathalon DH
46. Mittal VA
47. Mourgues C
48. Nordentoft M
49. Pasternak O
50. Pearlson GD
51. Penzel N
52. Perez J
53. Perkins DO
54. Powers AR
55. Rogers J
56. Sabb FW
57. Schiffman J
58. Seitz-Holland J
59. Shah JL
60. Silverstein SM
61. Smesny S
62. Stone WS
63. Strauss GP
64. Thompson JL
65. Upthegrove R
66. Verma S
67. Wang J
68. Wolf DH
69. Yung AR
70. Zhang T
71. Addamo L
72. Buccilli K
73. Todd S
74. Dwyer D
75. Bearden CE
76. Kane JM
77. McGorry PD
78. Kahn RS
79. Shenton ME
80. Woods SW
Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program.; Schizophrenia bulletin open; Vol 6(1), pp. sgaf013. 2025 Aug 25.
1. Addington J
2. Liu L
3. Chu M
4. Jungert K
5. Penzel N
6. Pasternak O
7. Farina E
8. Carrion RE
9. Corcoran CM
10. Mittal VA
11. Strauss GP
12. Yung AR
13. Alameda L
14. Arango C
15. Borders O
16. Bouix S
17. Breitborde NJK
18. Broome MR
19. Cadenhead KS
20. Castillo-Passi RI
21. Chen EYH
22. Choi J
23. Coleman MJ
24. Conus P
25. Diaz-Caneja CM
26. Ellman LM
27. Poli PF
28. Gaspar PA
29. Gerber C
30. Glenthøj LB
31. Horton LE
32. Hui CLM
33. Kambeitz J
34. Kambeitz-Ilankovic L
35. Kapur T
36. Kelly S
37. Kerr MJ
38. Keshavan MS
39. Kim M
40. Kim SW
41. Koutsouleris N
42. Kwon JS
43. Langbein K
44. Lewandowski KE
45. Mamah D
46. Marcy PJ
47. Mathalon DH
48. Mourgues C
49. Nordentoft M
50. Nunez AR
51. Pearlson GD
52. Perez J
53. Perkins DO
54. Powers AR
55. Rogers J
56. Sabb FW
57. Schiffman J
58. Seitz-Holland J
59. Shah JL
60. Silverstein SM
61. Smesny S
62. Stone WS
63. Thompson JL
64. Upthegrove R
65. Verma S
66. Wang J
67. Wolf DH
68. Zhang T
69. Addamo L
70. Buccilli K
71. Dwyer D
72. Todd S
73. Cho YT
74. Fontenau C
75. Tamayo Z
76. Bearden CE
77. Kane JM
78. McGorry PD
79. Kahn RS
80. Shenton ME
81. Woods SW
82. Calkins ME
Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program.; Schizophrenia bulletin open; Vol 6(1), pp. sgaf012. 2025 Aug 25.
1. Williams TF
2. Gold JM
3. Waltz JA
4. Schiffman J
5. Ellman LM
6. Strauss GP
7. Walker EF
8. Woods SW
9. Powers AR
10. Kenney J
11. Pappu MK
12. Corlett PR
13. Tran T
14. Silverstein SM
15. Zinbarg RE
16. Mittal VA
Identifying individuals at clinical high risk for psychosis using a battery of tasks sensitive to symptom mechanisms.; Translational psychiatry; Vol 15(1), pp. 311. 2025 Aug 23.
1. Antaki F
2. Kerexeta-Sarriegi J
3. Reis APR
4. Zhu Z
5. Chen R
6. Hu W
7. Ge Z
8. Denniston A
9. Petzold A
10. Silverstein SM
11. Keane PA
12. Wagner SK
The association of retinal age gap with schizophrenia: a cross-sectional analysis.; Schizophrenia research; Vol 283, pp. 180-187. 2025 Jul 24.
1. Papaioannou O
2. Clark K
3. Ogbuagu NN
4. Silverstein SM
5. Thompson JL
6. Erickson MA
Theta-gamma phase-amplitude coupling in psychosis and healthy controls: Predicting working memory capacity across different tasks.; NeuroImage. Clinical; Vol 48, pp. 103839. 2025 Jul 03.
1. Mathalon DH
2. Nicholas S
3. Roach BJ
4. Billah T
5. Lavoie S
6. Whitford T
7. Hamilton HK
8. Addamo L
9. Anohkin A
10. Bekinschtein T
11. Belger A
12. Buccilli K
13. Cahill J
14. Carrión RE
15. Damiani S
16. Dzafic I
17. Ebdrup BH
18. Izyurov I
19. Jarcho J
20. Jenni R
21. Jo A
22. Kerins S
23. Lee C
24. Martin EA
25. Mayol-Troncoso R
26. Niznikiewicz MA
27. Parvaz M
28. Pogarell O
29. Prieto-Montalvo J
30. Rabin R
31. Roalf DR
32. Rogers J
33. Salisbury DF
34. Shaik R
35. Shankman S
36. Stevens MC
37. Suen YN
38. Swann NC
39. Tang X
40. Thompson JL
41. Tso I
42. Wenzel J
43. Zhou JH
44. Addington J
45. Alameda L
46. Arango C
47. Breitborde NJK
48. Broome MR
49. Cadenhead KS
50. Calkins ME
51. Castillo-Passi RI
52. Chen EYH
53. Choi J
54. Conus P
55. Corcoran CM
56. Cornblatt BA
57. Diaz-Caneja CM
58. Ellman LM
59. Fusar-Poli P
60. Gaspar PA
61. Gerber C
62. Glenthøj LB
63. Horton LE
64. Hui CLM
65. Kambeitz J
66. Kambeitz-Ilankovic L
67. Keshavan MS
68. Kim M
69. Kim SW
70. Koutsouleris N
71. Kwon JS
72. Langbein K
73. Mamah D
74. Mittal VA
75. Nordentoft M
76. Pearlson GD
77. Perez J
78. Perkins DO
79. Powers AR
80. Sabb FW
81. Schiffman J
82. Shah JL
83. Silverstein SM
84. Smesny S
85. Stone WS
86. Strauss GP
87. Upthegrove R
88. Verma SK
89. Wang J
90. Wolf DH
91. Zhang T
92. Bouix S
93. Pasternak O
94. Cho KK
95. Coleman MJ
96. Dwyer D
97. Nunez A
98. Tamayo Z
99. Wood SJ
100. Kahn RS
101. Kane JM
102. McGorry PD
103. Bearden CE
104. Nelson B
105. Woods SW
106. Shenton ME
107. Light GA
The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures.; Schizophrenia (Heidelberg, Germany); Vol 11(1), pp. 85. 2025 Jun 06.
1. Wigman JTW
2. Ching AE
3. Chung Y
4. Eichi HR
5. Lane E
6. Langholm C
7. Vaidyam A
8. Byun AJS
9. Haidar A
10. Hartmann J
11. Nunez A
12. Dwyer D
13. Nasarudin AA
14. Borders O
15. Scott I
16. Tamayo Z
17. Matneja P
18. Cho KI
19. Addington J
20. Alameda LK
21. Arango C
22. Breitborde NJK
23. Broome MR
24. Cadenhead KS
25. Calkins ME
26. Chen EYH
27. Choi J
28. Conus P
29. Corcoran CM
30. Cornblatt BA
31. Diaz-Caneja CM
32. Ellman LM
33. Fusar-Poli P
34. Gaspar PA
35. Gerber C
36. Glenthøj LB
37. Horton LE
38. Hui CLM
39. Kambeitz J
40. Kambeitz-Ilankovic L
41. Keshavan MS
42. Kim SW
43. Koutsouleris N
44. Langbein K
45. Mamah D
46. Mathalon DH
47. Mittal VA
48. Nordentoft M
49. Pearlson GD
50. Perez J
51. Perkins DO
52. Powers AR
53. Rogers J
54. Sabb FW
55. Schiffman J
56. Shah JL
57. Silverstein SM
58. Smesny S
59. Yassin W
60. Stone WS
61. Strauss GP
62. Thompson JL
63. Upthegrove R
64. Verma S
65. Wang J
66. Wolf DH
67. Wolff P
68. Rowland LM
69. D'Alfonso S
70. Pasternak O
71. Bouix S
72. McGorry PD
73. Kahn RS
74. Kane JM
75. Bearden CE
76. Woods SW
77. Shenton ME
78. Nelson B
79. Baker JT
80. Torous J
Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program.; Schizophrenia (Heidelberg, Germany); Vol 11(1), pp. 83. 2025 Jun 03.
1. Tran T
2. Keane BP
3. Thompson JL
4. Robinson B
5. Kenney J
6. Williams TF
7. Waltz JA
8. Levin JA
9. Kafadar E
10. Gold JM
11. Schiffman J
12. Ellman LM
13. Walker EF
14. Strauss GP
15. Mittal VA
16. Zinbarg RE
17. Corlett PR
18. Powers AR
19. Woods SW
20. Silverstein SM
Increased face perception in individuals at clinical high-risk for psychosis: mechanisms, sex differences, and clinical correlates.; Schizophrenia (Heidelberg, Germany); Vol 11(1), pp. 74. 2025 May 12.
1. Krukow P
2. Domagała A
3. Kiersztyn A
4. Blose BA
5. Lai A
6. Silverstein SM
The Retinal Age Gap as a Marker of Accelerated Aging in the Early Course of Schizophrenia.; Schizophrenia bulletin. 2025 Apr 14.
1. Pokorny V
2. Tran T
3. Williams TF
4. Kenney J
5. Silverstein SM
6. Gold JM
7. Waltz JA
8. Schiffman J
9. Ellman LM
10. Strauss GP
11. Walker EF
12. Woods SW
13. Powers AR
14. Corlett PR
15. Mittal VA
Functional correlates of atypical visuoperceptual organization in a multisite clinical high-risk sample.; Journal of psychopathology and clinical science. 2025 Apr 07.
1. Kalender G
2. Olsen ST
3. Patzelt EH
4. Barch DM
5. Carter CS
6. Gold JM
7. Ragland JD
8. Silverstein SM
9. MacDonald AW
10. Widge AS
Test-retest reliability of computational parameters versus manifest behavior for decisional flexibility in psychosis.; Psychological assessment. 2025 Apr 07.
1. Addington J
2. Liu L
3. Braun A
4. Auther A
5. Calkins ME
6. Cornblatt BA
7. Corcoran CM
8. Fusar-Poli P
9. Kerr MJ
10. Mourgues-Codern CV
11. Nunez AR
12. Oliver D
13. Strauss GP
14. Walsh BC
15. Alameda LK
16. Arango C
17. Breitborde NJK
18. Broome MR
19. Cadenhead KS
20. Carrion RE
21. Chen EYH
22. Choi J
23. Coleman MJ
24. Conus P
25. Diaz-Caneja CM
26. Dwyer D
27. Ellman LM
28. Faghankhani M
29. Gaspar PA
30. Gerber C
31. Glenthøj LB
32. Horton LE
33. Hui C
34. Jacobs GR
35. Kambeitz J
36. Kambeitz-Ilankovic L
37. Keshavan MS
38. Kim SW
39. Koutsouleris N
40. Kwon JS
41. Langbein K
42. Lewandowski KE
43. Mamah D
44. Marcy PJ
45. Mathalon DH
46. Mittal VA
47. Nordentoft M
48. Pearlson GD
49. Penzel N
50. Perez J
51. Perkins DO
52. Powers AR
53. Rogers J
54. Sabb FW
55. Schiffman J
56. Shah JL
57. Silverstein SM
58. Smesny S
59. Stone WS
60. Thompson A
61. Thompson JL
62. Upthegrove R
63. Verma S
64. Wang J
65. Wastler HM
66. Wickham A
67. Rossum IW
68. Wolf DH
69. Bouix S
70. Pasternak O
71. Kahn RS
72. Bearden CE
73. Kane JM
74. McGorry PD
75. Buccilli K
76. Nelson B
77. Shenton ME
78. Woods SW
79. Yung AR
Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program.; Schizophrenia (Heidelberg, Germany); Vol 11(1), pp. 54. 2025 Apr 03.
1. Harms MP
2. Cho KK
3. Anticevic A
4. Bolo NR
5. Bouix S
6. Campbell D
7. Cannon TD
8. Cecchi G
9. Goncalves M
10. Haidar A
11. Hughes DE
12. Izyurov I
13. John O
14. Kapur T
15. Kim N
16. Kotler E
17. Kubicki M
18. Kuperman JM
19. Laulette K
20. Lindberg U
21. Markiewicz C
22. Ning L
23. Poldrack RA
24. Rathi Y
25. Romo PA
26. Tamayo Z
27. Wannan C
28. Wickham A
29. Yassin W
30. Zhou JH
31. Addington J
32. Alameda L
33. Arango C
34. Breitborde NJK
35. Broome MR
36. Cadenhead KS
37. Calkins ME
38. Chen EYH
39. Choi J
40. Conus P
41. Corcoran CM
42. Cornblatt BA
43. Diaz-Caneja CM
44. Ellman LM
45. Fusar-Poli P
46. Gaspar PA
47. Gerber C
48. Glenthøj LB
49. Horton LE
50. Hui CLM
51. Kambeitz J
52. Kambeitz-Ilankovic L
53. Keshavan MS
54. Kim SW
55. Koutsouleris N
56. Kwon JS
57. Langbein K
58. Mamah D
59. Mathalon DH
60. Mittal VA
61. Nordentoft M
62. Pearlson GD
63. Perez J
64. Perkins DO
65. Powers AR
66. Rogers J
67. Sabb FW
68. Schiffman J
69. Shah JL
70. Silverstein SM
71. Smesny S
72. Stone WS
73. Strauss GP
74. Thompson JL
75. Upthegrove R
76. Verma SK
77. Wang J
78. Wolf DH
79. Kahn RS
80. Kane JM
81. McGorry PD
82. Nelson B
83. Woods SW
84. Shenton ME
85. Wood SJ
86. Bearden CE
87. Pasternak O
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program.; Schizophrenia (Heidelberg, Germany); Vol 11(1), pp. 52. 2025 Apr 02.
1. Bailey A
2. Bauer BW
3. Mittal VA
4. Ellman LM
5. Strauss GP
6. Walker EF
7. Powers AR
8. Kenney J
9. Corlett PR
10. Woods SW
11. Gold JM
12. Schiffman J
13. Waltz JA
14. Silverstein SM
Interpersonal difficulties and suicidal ideation in young people at clinical high-risk for psychosis and help-seeking clinical controls.; Psychiatry research; Vol 348, pp. 116467. 2025 Mar 25.
1. Allott K
2. Yassin W
3. Alameda L
4. Billah T
5. Borders O
6. Buccilli K
7. Carrión RE
8. Castillo-Passi RI
9. Cho KIK
10. Chin K
11. Coleman MJ
12. Colton BL
13. Corral S
14. Dwyer D
15. Gundersen KB
16. Gur RC
17. Hoftman GD
18. Jacobs GR
19. Kelly S
20. Lewandowski KE
21. Marcy PJ
22. Matneja P
23. McLaughlin D
24. Nunez AR
25. Parsa S
26. Penzel N
27. Ray S
28. Reinen JM
29. Ruparel K
30. Sand MS
31. Santorelli G
32. Seitz-Holland J
33. Spark J
34. Tamayo Z
35. Thompson A
36. Tod S
37. Wannan CMJ
38. Wickham A
39. Wood SJ
40. Zoupou E
41. Addington J
42. Anticevic A
43. Arango C
44. Breitborde NJK
45. Broome MR
46. Cadenhead KS
47. Calkins ME
48. Chen EYH
49. Choi J
50. Conus P
51. Corcoran CM
52. Cornblatt BA
53. Ellman LM
54. Fusar-Poli P
55. Gaspar PA
56. Gerber C
57. Glenthøj LB
58. Horton LE
59. Hui CLM
60. Kambeitz J
61. Kambeitz-Ilankovic L
62. Keshavan M
63. Kim SW
64. Koutsouleris N
65. Kwon JS
66. Langbein K
67. Mamah D
68. Diaz-Caneja CM
69. Mathalon DH
70. Mittal VA
71. Nordentoft M
72. Pearlson GD
73. Perkins DO
74. Perez J
75. Powers AR
76. Rogers J
77. Sabb FW
78. Schiffman J
79. Shah JL
80. Silverstein SM
81. Smesny S
82. Strauss GP
83. Thompson JL
84. Upthegrove R
85. Verma SK
86. Wang J
87. Wolf DH
88. Pasternak O
89. Bouix S
90. McGorry PD
91. Kane JM
92. Kahn RS
93. Bearden CE
94. Shenton ME
95. Woods SW
96. Nelson B
97. Stone WS
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample.; Schizophrenia (Heidelberg, Germany); Vol 11(1), pp. 49. 2025 Mar 24.
1. MacDonald AW
2. Patzelt E
3. Kurth-Nelson Z
4. Barch DM
5. Carter CS
6. Gold JM
7. Ragland JD
8. Silverstein SM
Computational modeling of reversal learning impairments in schizophrenia and bipolar disorder reveals shared failure to exploit rewards.; Journal of psychopathology and clinical science. 2025 Mar 10.
1. Kaiser KA
2. Thompson JL
3. Butler PD
4. Ahmed AO
5. Seitz AR
6. Sobeih T
7. Silverstein SM
Effects of visual remediation on Ebbinghaus illusion task performance in people with schizophrenia: A preliminary study.; Schizophrenia research; Vol 277, pp. 57-64. 2025 Feb 27.
1. Spilka MJ
2. Millman ZB
3. Waltz JA
4. Walker EF
5. Levin JA
6. Powers AR
7. Corlett PR
8. Schiffman J
9. Gold JM
10. Silverstein SM
11. Ellman LM
12. Mittal VA
13. Woods SW
14. Zinbarg R
15. Strauss GP
A generalized reward processing deficit pathway to negative symptoms across diagnostic boundaries.; Psychological medicine; Vol 55, pp. e6. 2025 Feb 04.
1. Luther L
2. Ahmed AO
3. Grant PM
4. Granholm E
5. Gold JM
6. Williams TF
7. Pratt D
8. Holden J
9. Walker EF
10. Arnold L
11. Ellman LM
12. Mittal VA
13. Zinbarg R
14. Silverstein SM
15. Corlett PR
16. Powers AR
17. Woods SW
18. Waltz JA
19. Schiffman J
20. Strauss GP
Revisiting the Defeatist Performance Belief Scale in Adults With Schizophrenia and Youth at Clinical High-Risk for Psychosis: A Comprehensive Psychometric Analysis.; Schizophrenia bulletin. 2025 Jan 02.
1. Karczmarek P
2. Plechawska-Wójcik M
3. Kiersztyn A
4. Domagała A
5. Wolinska A
6. Silverstein SM
7. Jonak K
8. Krukow P
On the improvement of schizophrenia detection with optical coherence tomography data using deep neural networks and aggregation functions.; Scientific reports; Vol 14(1), pp. 31903. 2024 Dec 30.
1. Bergson Z
2. Ahmed AO
3. Bell J
4. Butler PD
5. Gordon J
6. Seitz AR
7. Silverstein SM
8. Thompson JL
9. Zemon V
Visual remediation of contrast processing impairments in schizophrenia: A preliminary clinical trial.; Schizophrenia research; Vol 274, pp. 396-405. 2024 Oct 30.
1. Keane BP
2. Silverstein SM
3. Papathomas TV
4. Krekelberg B
Correcting visual acuity beyond 20/20 improves contour element detection and integration: A cautionary tale for studies of special populations.; PloS one; Vol 19(9), pp. e0310678. 2024 Sep 26.
1. Silverstein SM
The Potential Utility of Retinal Biomarkers to Index Central Nervous System Effects of Repetitive Blast Exposure in Military Personnel.; Military medicine. 2024 Sep 18.
1. Sheehan N
2. Bannai D
3. Silverstein SM
4. Lizano P
Neuroretinal Alterations in Schizophrenia and Bipolar Disorder: An Updated Meta-analysis.; Schizophrenia bulletin; Vol 50(5), pp. 1067-1082. 2024 Aug 27.
1. Ifrah C
2. Herrera SN
3. Silverstein SM
4. Corcoran CM
5. Gordon J
6. Butler PD
7. Zemon V
The Relationship between Clinical and Psychophysical Assessments of Visual Perceptual Disturbances in Individuals at Clinical High Risk for Psychosis: A Preliminary Study.; Brain sciences; Vol 14(8). 2024 Aug 16.
1. Erickson MA
2. Boudewyn MA
3. Winsler K
4. Li C
5. Barch DM
6. Carter CS
7. Frank MJ
8. Gold JM
9. MacDonald AW
10. Ragland JD
11. Silverstein SM
12. Yonelinas A
13. Luck SJ
Dysfunctional Alpha Modulation as a Mechanism of Working Memory Impairment in Serious Mental Illness.; Biological psychiatry. Cognitive neuroscience and neuroimaging. 2024 Aug 06.
1. Rossi-Goldthorpe R
2. Silverstein SM
3. Gold JM
4. Schiffman J
5. Waltz JA
6. Williams TF
7. Powers AR
8. Woods SW
9. Zinbarg RE
10. Mittal VA
11. Ellman LM
12. Strauss GP
13. Walker EF
14. Levin JA
15. Castiello S
16. Kenney J
17. Corlett PR
Different learning aberrations relate to delusion-like beliefs with different contents.; Brain : a journal of neurology; Vol 147(8), pp. 2854-2866. 2024 Aug 01.
1. Blose BA
2. Silverstein SM
3. Stuart KV
4. Keane PA
5. Khawaja AP
6. Wagner SK
Association between polygenic risk for schizophrenia and retinal morphology: A cross-sectional analysis of the United Kingdom Biobank.; Psychiatry research; Vol 339, pp. 116106. 2024 Jul 26.
1. Defayette AB
2. Silverstein SM
3. Pisani AR
Social network structure as a biopsychosocial suicide prevention target for young people at clinical high-risk for psychosis.; Schizophrenia research; Vol 270, pp. 63-67. 2024 Jun 11.
1. Lu W
2. Mueser KT
3. Yanos PT
4. Jia Y
5. Siriram A
6. Bullock D
7. Wang K
8. Silverstein SM
9. Gottlieb J
10. Rogers K
11. Aftab PG
12. Rosenberg SD
Factor structure of posttraumatic stress disorder (PTSD) in persons with serious mental illness.; Journal of mental health (Abingdon, England); Vol 33(3), pp. 366-375. 2024 May 28.
1. Boudewyn MA
2. Erickson MA
3. Winsler K
4. Barch DM
5. Carter CS
6. Frank MJ
7. Gold JM
8. MacDonald AW
9. Ragland JD
10. Silverstein SM
11. Yonelinas AP
12. Luck SJ
Assessing Trial-by-Trial Electrophysiological and Behavioral Markers of Attentional Control and Sensory Precision in Psychotic and Mood Disorders.; Schizophrenia bulletin. 2024 Apr 14.
1. Jayakumar S
2. Ahmed AO
3. Butler PD
4. Silverstein SM
5. Thompson JL
6. Seitz AR
Performance on a contour integration task as a function of contour shape in schizophrenia and controls.; Vision research; Vol 219, pp. 108394. 2024 Apr 04.
1. Culbreth AJ
2. Moran EK
3. Mahaphanit W
4. Erickson MA
5. Boudewyn MA
6. Frank MJ
7. Barch DM
8. MacDonald AW
9. Ragland JD
10. Luck SJ
11. Silverstein SM
12. Carter CS
13. Gold JM
A Transdiagnostic Study of Effort-Cost Decision-Making in Psychotic and Mood Disorders.; Schizophrenia bulletin; Vol 50(2), pp. 339-348. 2024 Mar 07.
1. Thakkar KN
2. Silverstein SM
3. Fattal J
4. Bao J
5. Slate R
6. Roberts D
7. Brascamp JW
Stronger tilt aftereffects in individuals diagnosed with schizophrenia spectrum disorders but not bipolar disorder.; Schizophrenia research; Vol 264, pp. 345-353. 2024 Jan 12.
1. Bergson Z
2. Ahmed AO
3. Bell J
4. Gordon J
5. Seitz AR
6. Silverstein SM
7. Thompson JL
8. Zemon V
9. Butler PD
Visual remediation of contrast processing impairments in schizophrenia: a preliminary clinical trial; Schizophrenia Research. 2024 Jan 01.
1. Lizano PL
2. Silverstein SM
The Retina as a Biomarker in Neuropsychiatric Disorders; Biomarkers in Neuropsychiatry. 2024 Jan 01.
1. Silverstein SM
2. Atlas J
3. Young MA
4. Bertolace L
5. Juskiewicz I
6. Merchant-Borna K
7. Dermady S
8. Abrham Y
9. Green G
10. Bazarian J
11. Ramchandran J
12. Keane BP
Football-related concussions and head impacts are associated with changes in retinal structure and signaling; Biomarkers in Neuropsychiatry; Vol 10. 2024 Jan 01.
1. Velez-Perez E
2. Raymond N
3. Kiely C
4. Molho W
5. Trotti R
6. Harris C
7. Bannai D
8. Hegde R
9. Herold S
10. Keshavan M
11. Silverstein S
12. Lizano P
Electroretinographic dysfunction, insulin resistance, and childhood trauma in early-course psychosis: A case-control exploratory study; Biomarkers in Neuropsychiatry; Vol 10. 2024 Jan 01.
1. Vohs J
2. Srihari V
3. Vinson AH
4. Lapidos A
5. Cahill J
6. Taylor SF
7. Heckers S
8. Weiss A
9. Chaudhry S
10. Silverstein SM
11. Tso IF
12. Breitborde N
13. Breier A
The Academic Community Early Psychosis Intervention Network (AC-EPINET): Toward building a novel learning health system across six U.S. states.; Learning Health Systems.. 2024 Jan 01.
1. MacDonald AI
2. Patzelt E
3. Kurth-Nelson Z
4. Barch DM
5. Carter CS
6. Gold JM
7. Ragland JD
8. Silverstein SM
9. Strauss ME
Computational modeling of reversal learning impairments in schizophrenia and bipolar disorder reveals shared failure to exploit rewards; Journal of Psychopathology and Clinical Science. 2024 Jan 01.
1. Lu W
2. Srijeyanthan J
3. Siriram A
4. Silverstein SM
5. Yanos PT
6. Mueser KT
7. Gottlieb JD
8. Marcello S
9. Kim MJ
10. Zeiss M
Diagnostic profiles and trauma history among treatment-seeking young adults with positive post-traumatic stress disorder screens: Findings and implications for public mental health care.; Early intervention in psychiatry; Vol 18(5), pp. 381-388. 2023 Dec 13.
1. Komatsu H
2. Onoguchi G
3. Silverstein SM
4. Jerotic S
5. Sakuma A
6. Kanahara N
7. Kakuto Y
8. Ono T
9. Yabana T
10. Nakazawa T
11. Tomita H
Retina as a potential biomarker in schizophrenia spectrum disorders: a systematic review and meta-analysis of optical coherence tomography and electroretinography.; Molecular psychiatry; Vol 29(2), pp. 464-482. 2023 Dec 11.
1. Pratt DN
2. Luther L
3. Kinney KS
4. Osborne KJ
5. Corlett PR
6. Powers AR
7. Woods SW
8. Gold JM
9. Schiffman J
10. Ellman LM
11. Strauss GP
12. Walker EF
13. Zinbarg R
14. Waltz JA
15. Silverstein SM
16. Mittal VA
Comparing a Computerized Digit Symbol Test to a Pen-and-Paper Classic.; Schizophrenia bulletin open; Vol 4(1), pp. sgad027. 2023 Sep 28.
1. Fradkin SI
2. Bannai D
3. Lizano P
4. Lai A
5. Crosta C
6. Silverstein SM
Poster Session: Deep retinal layer microvasculature alterations in first episode and chronic schizophrenia.; Journal of vision; Vol 23(11), pp. 50. 2023 Sep 01.
1. Silverstein SM
Invited Session V: The eye as a window to systemic and neurodegenerative health: Disturbances of retinal structure in schizophrenia spectrum disorders and their clinical implications.; Journal of vision; Vol 23(11), pp. 28. 2023 Sep 01.
1. Blose BA
2. Lai A
3. Crosta C
4. Thompson JL
5. Silverstein SM
Retinal Neurodegeneration as a Potential Biomarker of Accelerated Aging in Schizophrenia Spectrum Disorders.; Schizophrenia bulletin. 2023 Jul 17.
1. Dalloul N
2. Moran EK
3. Gold JM
4. Carter CS
5. MacDonald AW
6. Ragland JD
7. Silverstein SM
8. Luck SJ
9. Barch DM
Transdiagnostic Predictors of Everyday Functioning: Examining the Relationships of Depression and Reinforcement Learning.; Schizophrenia bulletin. 2023 Jun 29.
1. Boudewyn MA
2. Erickson MA
3. Winsler K
4. Ragland JD
5. Yonelinas A
6. Frank M
7. Silverstein SM
8. Gold J
9. MacDonald AW
10. Carter CS
11. Barch DM
12. Luck SJ
Managing EEG studies: How to prepare and what to do once data collection has begun.; Psychophysiology. 2023 Jun 14.
1. Lu W
2. Mueser KT
3. Yanos PT
4. Siriram A
5. Jia Y
6. Leong A
7. Silverstein SM
8. Gottlieb J
9. Jankowski MK
Post-Traumatic Cognitions Inventory (PTCI): psychometric properties in clients with serious mental illness and co-occurring PTSD.; Behavioural and cognitive psychotherapy. 2023 May 22.
1. Wagner SK
2. Cortina-Borja M
3. Silverstein SM
4. Zhou Y
5. Romero-Bascones D
6. Struyven RR
7. Trucco E
8. Mookiah MRK
9. MacGillivray T
10. Hogg S
11. Liu T
12. Williamson DJ
13. Pontikos N
14. Patel PJ
15. Balaskas K
16. Alexander DC
17. Stuart KV
18. Khawaja AP
19. Denniston AK
20. Rahi JS
21. Petzold A
22. Keane PA
Association Between Retinal Features From Multimodal Imaging and Schizophrenia.; JAMA psychiatry. 2023 Mar 22.
1. Karp EL
2. Williams TF
3. Ellman LM
4. Strauss GP
5. Walker EF
6. Corlett PR
7. Woods SW
8. Powers AR
9. Gold JM
10. Schiffman JE
11. Waltz JA
12. Silverstein SM
13. Mittal VA
Self-reported Gesture Interpretation and Performance Deficits in Individuals at Clinical High Risk for Psychosis.; Schizophrenia bulletin. 2023 Mar 20.
1. Williams TF
2. Walker EF
3. Strauss GP
4. Woods SW
5. Powers AR
6. Corlett PR
7. Schiffman J
8. Waltz JA
9. Gold JM
10. Silverstein SM
11. Ellman LM
12. Zinbarg RE
13. Mittal VA
The reliability and validity of the revised Green et al. paranoid thoughts scale in individuals at clinical high-risk for psychosis.; Acta psychiatrica Scandinavica. 2023 Mar 11.
1. Wittink M
2. Chan AC
3. Padrino S
4. Silverstein SM
The Undervalued Potential of Medical-Psychiatry Units to Improve Care for People With Severe Mental Illnesses.; Psychiatric services (Washington, D.C.). 2023 Feb 23.
1. Shoham N
2. Lewis G
3. Hayes JF
4. Silverstein SM
5. Cooper C
Association between visual impairment and psychosis: A longitudinal study and nested case-control study of adults.; Schizophrenia research; Vol 254, pp. 81-89. 2023 Feb 17.
1. Barch DM
2. Boudewyn MA
3. Carter CC
4. Erickson M
5. Frank MJ
6. Gold JM
7. Luck SJ
8. MacDonald AW
9. Ragland JD
10. Ranganath C
11. Silverstein SM
12. Yonelinas A
Cognitive [Computational] Neuroscience Test Reliability and Clinical Applications for Serious Mental Illness (CNTRaCS) Consortium: Progress and Future Directions.; Current topics in behavioral neurosciences; Vol 63, pp. 19-60. 2023.
1. Lu W
2. Srijeyanthan J
3. Siriram A
4. Silverstein SM
5. Yanos PT
6. Mueser KT
7. Gottlieb JD
8. Marcello S
9. Kim M
10. Zeiss M
Diagnostic profiles and trauma history among treatment-seeking young adults with positive PTSD screens: Findings and implications for public mental health care; Early Intervention in Psychiatry; Vol 18(5), pp. 381-388. 2023 Jan 01.
1. Diamond A
2. Silverstein SM
3. Keane BP
Visual system assessment for predicting a transition to psychosis.; Translational psychiatry; Vol 12(1), pp. 351. 2022 Aug 29.
1. Papaioannou O
2. Crespo LP
3. Clark K
4. Ogbuagu NN
5. Alliende LM
6. Silverstein SM
7. Erickson MA
Is Cortical Theta-Gamma Phase-Amplitude Coupling Memory-Specific?; Brain sciences; Vol 12(9). 2022 Aug 25.
1. Demmin DL
2. Silverstein SM
3. Shors TJ
Mental and physical training with meditation and aerobic exercise improved mental health and well-being in teachers during the COVID-19 pandemic.; Frontiers in human neuroscience; Vol 16, pp. 847301. 2022 Aug 23.
1. Lu W
2. Silverstein SM
3. Mueser KT
4. Minsky S
5. Bullock D
6. Buchbinder S
7. Chen Q
8. Eubanks R
9. Guillaume-Salvant A
Undocumented PTSD among African American clients with serious mental illness in a statewide mental health system.; Psychological trauma : theory, research, practice and policy. 2022 Jul 07.
1. Silverstein SM
2. Choi JJ
3. Green KM
4. Bowles-Johnson KE
5. Ramchandran RS
Schizophrenia in Translation: Why the Eye?; Schizophrenia bulletin. 2022 May 28.
1. Williams TF
2. Powers AR
3. Ellman LM
4. Corlett PR
5. Strauss GP
6. Schiffman J
7. Waltz JA
8. Silverstein SM
9. Woods SW
10. Walker EF
11. Gold JM
12. Mittal VA
Three prominent self-report risk measures show unique and overlapping utility in characterizing those at clinical high-risk for psychosis.; Schizophrenia research; Vol 244. 2022 May 18.
1. Kwashie AN
2. Ma Y
3. Barch DM
4. Chafee M
5. Ragland JD
6. Silverstein SM
7. Carter CS
8. Gold JM
9. MacDonald AW
Comparing the functional neuroanatomy of proactive and reactive control between patients with schizophrenia and healthy controls.; Cognitive, affective & behavioral neuroscience; Vol 23(1), pp. 203-215. 2022 Jan 23.
1. Lu W
2. Srijeyanthan J
3. Mueser KT
4. Yanos PT
5. Parrott JS
6. Siriram A
7. Gottlieb JD
8. Marcello S
9. Silverstein SM
Predictors of undocumented PTSD in persons using public mental health services.; Psychiatry research; Vol 317, pp. 114892. 2022 Jan 13.
1. Keane BP
2. Krekelberg B
3. Mill RD
4. Silverstein SM
5. Thompson JL
6. Serody MR
7. Barch DM
8. Cole MW
Dorsal attention network activity during perceptual organization is distinct in schizophrenia and predictive of cognitive disorganization.; The European journal of neuroscience. 2022 Jan 11.
1. Green KM
2. Choi JJ
3. Ramchandran RS
4. Silverstein SM
OCT and OCT Angiography Offer New Insights and Opportunities in Schizophrenia Research and Treatment.; Frontiers in digital health; Vol 4. 2022.
1. Joseph D
2. Lai A
3. Silverstein S
4. Ramchandran R
5. Bernal EA
Computer vision-based classification of schizophrenia patients from retinal imagery; Proceedings of the IS&T International Symposium on Electronic Imaging: Image Processing: Algorithms and Systems. 2022 Jan 01.
1. Fradkin SI
2. Silverstein SM
Resistance to depth inversion illusions: A biosignature of psychosis with potential utility for monitoring positive symptom emergence and remission in schizophrenia; Biomarkers in Neuropsychiatry; Vol 6. 2022 Jan 01.
1. Silverstein SM
2. Sörensen S
3. Sunkara A
4. Lai A
5. Fradkin SI
6. Ramchandran RS
Association of vision loss and depressive symptomatology in older adults assessed for ocular health in senior living facilities.; Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists). 2021 Aug 12.
1. Guterman Y
2. Ataria Y
3. Silverstein SM
The Imbalanced Plasticity Hypothesis of Schizophrenia-Related Psychosis: A Predictive Perspective.; Cognitive, affective & behavioral neuroscience. 2021 May 28.
1. Silverstein SM
2. Thompson JL
3. Gold JM
4. Schiffman J
5. Waltz JA
6. Williams TF
7. Zinbarg RE
8. Mittal VA
9. Ellman LM
10. Strauss GP
11. Walker EF
12. Woods SW
13. Levin JA
14. Kafadar E
15. Kenney J
16. Smith D
17. Powers AR
18. Corlett PR
Increased face detection responses on the mooney faces test in people at clinical high risk for psychosis.; NPJ schizophrenia; Vol 7(1). 2021 May 17.
1. Pratt DN
2. Barch DM
3. Carter CS
4. Gold JM
5. Ragland JD
6. Silverstein SM
7. MacDonald AW
Reliability and Replicability of Implicit and Explicit Reinforcement Learning Paradigms in People With Psychotic Disorders.; Schizophrenia bulletin; Vol 47(3). 2021 Apr 29.
1. Keane BP
2. Barch DM
3. Mill RD
4. Silverstein SM
5. Krekelberg B
6. Cole MW
Brain network mechanisms of visual shape completion.; NeuroImage. 2021 Apr 17.
1. Geana A
2. Barch DM
3. Gold JM
4. Carter CS
5. MacDonald AW
6. Ragland JD
7. Silverstein SM
8. Frank MF
Using Computational Modelling to Capture Schizophrenia-Specific Reinforcement Learning Differences and Their Implications on Patient Classification.; Biological psychiatry. Cognitive neuroscience and neuroimaging. 2021 Apr 17.
1. Silverstein SM
2. Keane BP
3. Corlett PR
Oculomics in Schizophrenia Research.; Schizophrenia bulletin. 2021 Feb 19.
1. Jerotic S
2. Lalovic N
3. Pejovic S
4. Mihaljevic M
5. Pavlovic Z
6. Britvic D
7. Risimic D
8. Soldatovic I
9. Silverstein SM
10. Maric NP
Sex differences in macular thickness of the retina in patients with psychosis spectrum disorders.; Progress in neuro-psychopharmacology & biological psychiatry. 2021 Feb 07.
1. Silverstein SM
2. Wang Y
3. Roché MW
Corrigendum: Base Rates, Blindness, and Schizophrenia.; Frontiers in psychology; Vol 12. 2021.
1. Silverstein SM
2. Lai A
The Phenomenology and Neurobiology of Visual Distortions and Hallucinations in Schizophrenia: An Update.; Frontiers in psychiatry; Vol 12. 2021.
1. Mittal VA
2. Ellman LM
3. Strauss GP
4. Walker EF
5. Corlett PR
6. Schiffman J
7. Woods SW
8. Powers AR
9. Silverstein SM
10. Waltz JA
11. Zinbarg R
12. Chen S
13. Williams T
14. Kenney J
15. Gold JM
Computerized Assessment of Psychosis Risk.; Journal of psychiatry and brain science; Vol 6(3). 2021.
1. Silverstein SM
2. Lai A
3. Green KM
4. Crosta C
5. Fradkin SI
6. Ramchandran RS
Retinal Microvasculature in Schizophrenia.; Eye and brain; Vol 13. 2021.
1. Beaudette DM
2. Gold JM
3. Waltz J
4. Thompson JL
5. Cherneski L
6. Martin V
7. Monteiro B
8. Cruz LN
9. Silverstein SM
Predicting Attention-Shaping Response in People With Schizophrenia.; The Journal of nervous and mental disease. 2020 Dec 10.
1. Thakkar KN
2. Ghermezi L
3. Silverstein SM
4. Slate R
5. Yao B
6. Achtyes ED
7. Brascamp JW
Stronger tilt aftereffects in persons with schizophrenia.; Journal of abnormal psychology. 2020 Dec 10.
1. Netser R
2. Demmin DL
3. Dobkin R
4. Goldstein A
5. Roché M
6. Netser Zernik A
7. Silverstein SM
Flash Electroretinography Parameters and Parkinson's Disease.; Journal of Parkinson's disease. 2020 Oct 16.
1. Jerotic S
2. Ignjatovic Z
3. Silverstein SM
4. Maric NP
Structural imaging of the retina in psychosis spectrum disorders: current status and perspectives.; Current opinion in psychiatry; Vol 33(5). 2020 Sep.
1. Moran EK
2. Gold JM
3. Carter CS
4. MacDonald AW
5. Ragland JD
6. Silverstein SM
7. Luck SJ
8. Barch DM
Both unmedicated and medicated individuals with schizophrenia show impairments across a wide array of cognitive and reinforcement learning tasks.; Psychological medicine. 2020 Aug 17.
1. Almeida NL
2. Rodrigues SJ
3. Gonçalves LM
4. Silverstein SM
5. Sousa IC
6. Gomes GH
7. Butler PD
8. Fernandes TP
9. Santos NA
Opposite effects of smoking and nicotine intake on cognition.; Psychiatry research; Vol 293. 2020 Aug 03.
1. Gold JM
2. Corlett PR
3. Strauss GP
4. Schiffman J
5. Ellman LM
6. Walker EF
7. Powers AR
8. Woods SW
9. Waltz JA
10. Silverstein SM
11. Mittal VA
Enhancing Psychosis Risk Prediction Through Computational Cognitive Neuroscience.; Schizophrenia bulletin. 2020 Jul 10.
1. Kafadar E
2. Mittal VA
3. Strauss GP
4. Chapman HC
5. Ellman LM
6. Bansal S
7. Gold JM
8. Alderson-Day B
9. Evans S
10. Moffatt J
11. Silverstein SM
12. Walker EF
13. Woods SW
14. Corlett PR
15. Powers AR
Modeling perception and behavior in individuals at clinical high risk for psychosis: Support for the predictive processing framework.; Schizophrenia research. 2020 Jun 24.
1. Silverstein SM
2. Fradkin SI
3. Demmin DL
Schizophrenia and the retina: Towards a 2020 perspective.; Schizophrenia research; Vol 219. 2020 May.
1. Maziade M
2. Silverstein SM
The place of the retina in psychiatry: Uniting neurobiological and neurodevelopmental research with clinical research in psychiatric disorders.; Schizophrenia research; Vol 219. 2020 May.
1. Demmin DL
2. Mote J
3. Beaudette DM
4. Thompson JL
5. Silverstein SM
Retinal functioning and reward processing in schizophrenia.; Schizophrenia research; Vol 219. 2020 May.
1. Demmin DL
2. Netser R
3. Roché MW
4. Thompson JL
5. Silverstein SM
People with current major depression resemble healthy controls on flash Electroretinogram indices associated with impairment in people with stabilized schizophrenia.; Schizophrenia research; Vol 219. 2020 May.
1. Jerotic S
2. Ristic I
3. Pejovic S
4. Mihaljevic M
5. Pavlovic Z
6. Britvic D
7. Ignjatovic Z
8. Silverstein SM
9. Maric NP
Retinal structural abnormalities in young adults with psychosis spectrum disorders.; Progress in neuro-psychopharmacology & biological psychiatry; Vol 98. 2020 Mar 02.
1. Ray KL
2. Ragland JD
3. MacDonald AW
4. Gold JM
5. Silverstein SM
6. Barch DM
7. Carter CS
Dynamic reorganization of the frontal parietal network during cognitive control and episodic memory.; Cognitive, affective & behavioral neuroscience; Vol 20(1). 2020 Feb.
1. Silverstein SM
2. Thompson JL
Progress, Possibilities, and Pitfalls in Electroretinography Research in Psychiatry.; Biological psychiatry; Vol 87(3). 2020 Feb 01.
1. Silverstein SM
Issues in the Aggregation of Data on Retinal Structure and Function in Schizophrenia.; Schizophrenia bulletin; Vol 46(1). 2020 Jan 04.
1. Smucny J
2. Iosif AM
3. Eaton NR
4. Lesh TA
5. Ragland JD
6. Barch DM
7. Gold JM
8. Strauss ME
9. MacDonald AW
10. Silverstein SM
11. Carter CS
Latent Profiles of Cognitive Control, Episodic Memory, and Visual Perception Across Psychiatric Disorders Reveal a Dimensional Structure.; Schizophrenia bulletin; Vol 46(1). 2020 Jan 04.
1. Silverstein SM
2. Seitz AR
3. Ahmed AO
4. Thompson JL
5. Zemon V
6. Gara M
7. Butler PD
Development and Evaluation of a Visual Remediation Intervention for People with Schizophrenia.; Journal of psychiatry and brain science; Vol 5. 2020.
1. Schenkel LS
2. Wilkniss SM
3. Savitz A
4. Spaulding WD
5. Silverstein SM
The effects of a staff-training program in behavior management and social-learning principles on staff-patient interactions within a psychiatric rehabilitation inpatient unit.; The American journal of orthopsychiatry; Vol 90(4). 2020.
1. Demmin DL
2. Silverstein SM
Visual Impairment and Mental Health: Unmet Needs and Treatment Options.; Clinical ophthalmology (Auckland, N.Z.); Vol 14. 2020.
1. Fradkin SI
2. Erickson MA
3. Demmin DL
4. Silverstein SM
Absence of Excess Intra-Individual Variability in Retinal Function in People With Schizophrenia.; Frontiers in psychiatry; Vol 11. 2020.
1. Beaudette DM
2. Cruz LN
3. Lukachko A
4. Roché M
5. Silverstein SM
Relationships Between Working Alliance and Outcomes in Group Therapy for People Diagnosed with Schizophrenia.; Psychosis; Vol 12(4). 2020.
1. Silverstein SM
2. Keane BP
3. Demmin DL
4. Fradkin SI
Visual Impairments in Schizophrenia: Their Significance and Unrealized Clinical Potential.; Psychiatria Danubina; Vol 32(1). 2020.
1. Lai A
2. Crosta C
3. Loftin M
4. Silverstein SM
Retinal structural alterations in chronic versus first episode schizophrenia spectrum disorders; Biomarkers in Neuropsychiatry; Vol 2. 2020 Jan 01.
1. Silverstein SM
2. Demmin DL
3. Schallek JB
4. Fradkin SI
Measures of retinal structure and function as biomarkers in neurology and psychiatry; Biomarkers in Neuropsychiatry; Vol 2. 2020 Jan 01.
1. Yanos PT
2. Lysaker PH
3. Silverstein SM
4. Vayshenker B
5. Gonzales L
6. West ML
7. Roe D
A randomized-controlled trial of treatment for self-stigma among persons diagnosed with schizophrenia-spectrum disorders.; Social psychiatry and psychiatric epidemiology; Vol 54(11). 2019 Nov.
1. Nikitova N
2. Keane BP
3. Demmin D
4. Silverstein SM
5. Uhlhaas PJ
The Audio-Visual Abnormalities Questionnaire (AVAQ): Development and validation of a new instrument for assessing anomalies in sensory perception in schizophrenia spectrum disorders.; Schizophrenia research; Vol 209. 2019 Jul.
1. Gold JM
2. Barch DM
3. Feuerstahler LM
4. Carter CS
5. MacDonald AW
6. Ragland JD
7. Silverstein SM
8. Strauss ME
9. Luck SJ
Working Memory Impairment Across Psychotic disorders.; Schizophrenia bulletin; Vol 45(4). 2019 Jun 18.
1. Thakkar KN
2. Silverstein SM
3. Brascamp JW
A review of visual aftereffects in schizophrenia.; Neuroscience and biobehavioral reviews; Vol 101. 2019 Jun.
1. Bennett D
2. Silverstein SM
3. Niv Y
The Two Cultures of Computational Psychiatry.; JAMA psychiatry; Vol 76(6). 2019 Jun 01.
1. Smucny J
2. Barch DM
3. Gold JM
4. Strauss ME
5. MacDonald AW
6. Boudewyn MA
7. Ragland JD
8. Silverstein SM
9. Carter CS
Cross-diagnostic analysis of cognitive control in mental illness: Insights from the CNTRACS consortium.; Schizophrenia research; Vol 208. 2019 Jun.
1. Fernandes TMP
2. Silverstein SM
3. Butler PD
4. Kéri S
5. Santos LG
6. Nogueira RL
7. Santos NA
Color vision impairments in schizophrenia and the role of antipsychotic medication type.; Schizophrenia research; Vol 204. 2019 Feb.
1. Gara MA
2. Minsky S
3. Silverstein SM
4. Miskimen T
5. Strakowski SM
A Naturalistic Study of Racial Disparities in Diagnoses at an Outpatient Behavioral Health Clinic.; Psychiatric services (Washington, D.C.); Vol 70(2). 2019 Feb 01.
1. Erickson MA
2. Smith D
3. Albrecht MA
4. Silverstein S
Alpha-band desynchronization reflects memory-specific processes during visual change detection.; Psychophysiology; Vol 56(11). 2019 Jan.
1. Fernandes TP
2. Silverstein SM
3. Almeida NL
4. Santos NA
Visual impairments in type 1 bipolar disorder.; The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry; Vol 20(10). 2019 Jan.
1. Fernandes TP
2. Silverstein SM
3. Almeida NL
4. Santos NA
Visual impairments in tobacco use disorder.; Psychiatry research; Vol 271. 2019 Jan.
1. Keane BP
2. Paterno D
3. Crespo LP
4. Kastner S
5. Silverstein SM
Smaller visual arrays are harder to integrate in schizophrenia: Evidence for impaired lateral connections in early vision.; Psychiatry research; Vol 282. 2019 Jan.
1. Keane BP
2. Paterno D
3. Kastner S
4. Krekelberg B
5. Silverstein SM
Intact illusory contour formation but equivalently impaired visual shape completion in first- and later-episode schizophrenia.; Journal of abnormal psychology; Vol 128(1). 2019 Jan.
1. Silverstein SM
2. Kourtev H
Retinal and cortical contributions to excessive V1 neuron firing rate variability in schizophrenia: A computational modeling analysis; Journal of Systems Biology; Vol 1, pp. 12-32. 2019 Jan 01.
1. Demmin D
2. Fradkin S
3. Silverstein SM
Remediation of visual processing impairments in schizophrenia: Where we are and where we need to be; Current Behavioral Neuroscience Reports; Vol 6, pp. 13-20. 2019 Jan 01.
1. Fernandes TMP
2. Silverstein SM
3. Almeida NL
4. Santos NAD
Psychophysical evaluation of contrast sensitivity using Gabor patches in tobacco addiction.; Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia; Vol 57. 2018 Nov.
1. Kurylo DD
2. Waxman R
3. Silverstein SM
4. Weinstein B
5. Kader J
6. Michalopoulos I
Remediation of perceptual organisation in schizophrenia.; Cognitive neuropsychiatry; Vol 23(5). 2018 Sep.
1. Silverstein SM
2. Paterno D
3. Cherneski L
4. Green S
Optical coherence tomography indices of structural retinal pathology in schizophrenia.; Psychological medicine; Vol 48(12). 2018 Sep.
1. Svane KC
2. Asis EK
3. Omelchenko A
4. Kunnath AJ
5. Brzustowicz LM
6. Silverstein SM
7. Firestein BL
d-Serine administration affects nitric oxide synthase 1 adaptor protein and DISC1 expression in sex-specific manner.; Molecular and cellular neurosciences; Vol 89. 2018 Jun.
1. Demmin DL
2. Davis Q
3. Roché M
4. Silverstein SM
Electroretinographic anomalies in schizophrenia.; Journal of abnormal psychology; Vol 127(4). 2018 May.
1. Roché MW
2. Boyle DJ
3. Cheng CC
4. Del Pozzo J
5. Cherneski L
6. Pascarella J
7. Lukachko A
8. Silverstein SM
Prevalence and Risk of Violent Ideation and Behavior in Serious Mental Illnesses: An Analysis of 63,572 Patient Records.; Journal of interpersonal violence. 2018 Mar 01.
1. Mote J
2. Grant PM
3. Silverstein SM
Treatment Implications of Situational Variability in Cognitive and Negative Symptoms of Schizophrenia.; Psychiatric services (Washington, D.C.); Vol 69(10). 2018 Jan 01.
1. Beck AT
2. Himelstein R
3. Bredemeier K
4. Silverstein SM
5. Grant P
What accounts for poor functioning in people with schizophrenia: a re-evaluation of the contributions of neurocognitive v. attitudinal and motivational factors.; Psychological medicine; Vol 48(16). 2018 Jan.
1. Keane BP
2. Cruz LN
3. Paterno D
4. Silverstein SM
Self-Reported Visual Perceptual Abnormalities Are Strongly Associated with Core Clinical Features in Psychotic Disorders.; Frontiers in psychiatry; Vol 9. 2018.
1. Keane BP
2. Peng Y
3. Demmin D
4. Silverstein SM
5. Lu H
Intact perception of coherent motion, dynamic rigid form, and biological motion in chronic schizophrenia.; Psychiatry research; Vol 268. 2018 Jan.
1. Slade EP
2. Gottlieb JD
3. Lu W
4. Yanos PT
5. Rosenberg S
6. Silverstein SM
7. Minsky SK
8. Mueser KT
Cost-Effectiveness of a PTSD Intervention Tailored for Individuals With Severe Mental Illness.; Psychiatric services (Washington, D.C.); Vol 68(12). 2017 Dec 01.
1. Silverstein SM
2. Demmin DL
3. Bednar JA
Computational Modeling of Contrast Sensitivity and Orientation Tuning in First-Episode and Chronic Schizophrenia.; Computational psychiatry (Cambridge, Mass.); Vol 1. 2017 Dec.
1. Kurylo DD
2. Waxman R
3. Kidron R
4. Silverstein SM
Visual training improves perceptual grouping based on basic stimulus features.; Attention, perception & psychophysics; Vol 79(7). 2017 Oct.
1. Silverstein SM
2. Wibral M
3. Phillips WA
Implications of Information Theory for Computational Modeling of Schizophrenia.; Computational psychiatry (Cambridge, Mass.); Vol 1. 2017 Oct.
1. Ermel J
2. Carter CS
3. Gold JM
4. MacDonald AW
5. Daniel Ragland J
6. Silverstein SM
7. Strauss ME
8. Barch DM
Self versus informant reports on the specific levels of functioning scale: Relationships to depression and cognition in schizophrenia and schizoaffective disorder.; Schizophrenia research. Cognition; Vol 9. 2017 Sep.
1. Barch DM
2. Carter CS
3. Gold JM
4. Johnson SL
5. Kring AM
6. MacDonald AW
7. Pizzagalli DA
8. Ragland JD
9. Silverstein SM
10. Strauss ME
Explicit and implicit reinforcement learning across the psychosis spectrum.; Journal of abnormal psychology; Vol 126(5). 2017 Jul.
1. Butler PD
2. Thompson JL
3. Seitz AR
4. Deveau J
5. Silverstein SM
Visual perceptual remediation for individuals with schizophrenia: Rationale, method, and three case studies.; Psychiatric rehabilitation journal; Vol 40(1). 2017 Mar.
1. Mullen MG
2. Thompson JL
3. Murphy AA
4. Malenczak D
5. Giacobbe G
6. Karyczak S
7. Holloway KE
8. Twamley EW
9. Silverstein SM
10. Gill KJ
Evaluation of a cognitive remediation intervention for college students with psychiatric conditions.; Psychiatric rehabilitation journal; Vol 40(1). 2017 Mar.
1. Silverstein SM
2. Demmin D
3. Skodlar B
Space and Objects: On the Phenomenology and Cognitive Neuroscience of Anomalous Perception in Schizophrenia (Ancillary Article to EAWE Domain 1).; Psychopathology; Vol 50(1). 2017.
1. Ray KL
2. Lesh TA
3. Howell AM
4. Salo TP
5. Ragland JD
6. MacDonald AW
7. Gold JM
8. Silverstein SM
9. Barch DM
10. Carter CS
Functional network changes and cognitive control in schizophrenia.; NeuroImage. Clinical; Vol 15. 2017.
1. Welch LC
2. Trudeau JJ
3. Silverstein SM
4. Sand M
5. Henderson DC
6. Rosen RC
Initial development of a patient-reported outcome measure of experience with cognitive impairment associated with schizophrenia.; Patient related outcome measures; Vol 8. 2017.
1. Satinover J
2. Silverstein SM
Jungian psychotherapy; Elsevier Reference Module in Neuroscience and Biobehavioral Psychology. 2017 Jan 01.
1. Pienkos E
2. Sass L
3. Silverstein SM
The Phenomenology of anomalous world experience in schizophrenia; Journal of Phenomenological Psychology; Vol 48(188-213). 2017 Jan 01.
1. Farkas A
2. Papathomas TV
3. Silverstein SM
4. Kourtev H
5. Papayanopoulos JF
Dynamic 3-D computer graphics for designing a diagnostic tool for patients with schizophrenia.; The Visual computer; Vol 32(11). 2016 Nov.
1. Poppe AB
2. Barch DM
3. Carter CS
4. Gold JM
5. Ragland JD
6. Silverstein SM
7. MacDonald AW
Reduced Frontoparietal Activity in Schizophrenia Is Linked to a Specific Deficit in Goal Maintenance: A Multisite Functional Imaging Study.; Schizophrenia bulletin; Vol 42(5). 2016 Sep.
1. Sheffield JM
2. Repovs G
3. Harms MP
4. Carter CS
5. Gold JM
6. MacDonald AW
7. Ragland JD
8. Silverstein SM
9. Godwin D
10. Barch DM
Evidence for Accelerated Decline of Functional Brain Network Efficiency in Schizophrenia.; Schizophrenia bulletin; Vol 42(3). 2016 May.
1. Nguyen J
2. Majmudar U
3. Papathomas TV
4. Silverstein SM
5. Torres EB
Schizophrenia: The micro-movements perspective.; Neuropsychologia; Vol 85. 2016 May.
1. Keane BP
2. Paterno D
3. Kastner S
4. Silverstein SM
Visual integration dysfunction in schizophrenia arises by the first psychotic episode and worsens with illness duration.; Journal of abnormal psychology; Vol 125(4). 2016 May.

Book chapters:

Graham, D., Silverstein, S. (2023). Art Making in Schizophrenia: A Vision Science Perspective. (pp. 113-142) In: Richard, A., Pelowski, M., Spee, B.T. (eds) Art and Neurological Disorders. Current Clinical Neurology. Humana, Cham. Springer Nature.

Silverstein, S.M., Demmin, D.L., & Fradkin, S.I. (2021) State-sensitive, clinician-friendly, and vision science-based markers of specific computational processes for monitoring symptoms and predicting outcomes in people with schizophrenia. (pp. 75-93). In L.M. Williams and L.M. Hack (Eds). Precision psychiatry. Washington DC: American Psychiatric Association.

Graham, D., & Silverstein, S. (in press). Art making in schizophrenia: A vision science perspective. In M. Pelowski, B. Spee, & A. Richard (Eds.), Art and neurodegenerative disease: Illuminating the intersection of illness and creativity. London: Springer Nature.